Novita Pharmaceuticals Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Novita Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company intended to develop drugs to prevent and treat cancer metastasis and boost anti-cancer immune responses. The company manufactures drugs using its proprietary fascin inhibitor technology and focuses on patients with metastatic breast cancer, enabling healthcare providers to cure their patients optimally and improve their quality of life.

Contact Information

Website
www.novita-pharm.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 445 Park Avenue
  • Suite 19A
  • New York, NY 10022
  • United States
+1 (914)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 445 Park Avenue
  • Suite 19A
  • New York, NY 10022
  • United States
+1 (914)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novita Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Dec-2023 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series A) 13-Dec-2021 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series A) 06-Apr-2017 Completed Pre-Clinical Trials
2. Seed Round 04-Jan-2011 $1.65M $1.65M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2010 Completed Pre-Clinical Trials
To view Novita Pharmaceuticals’s complete valuation and funding history, request access »

Novita Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Novita Pharmaceuticals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Novita Pharmaceuticals Patents

  • 49

    Total Documents Applications and Grants

  • Total Patents Families

  • 36

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

Novita Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3084512-A1 Co-therapies including a metastasis inhibitor Pending 22-Nov-2017
EP-3713570-A1 Co-therapies including a metastasis inhibitor Pending 22-Nov-2017
EP-3713570-A4 Co-therapies including a metastasis inhibitor Pending 22-Nov-2017
US-11701342-B2 Co-therapies including a metastasis inhibitor Active 22-Nov-2017
US-12508245-B2 Co-therapies including a metastasis inhibitor Active 22-Nov-2017 A61K31/4162
To view Novita Pharmaceuticals’s complete patent history, request access »

Novita Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novita Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cloudstone Capital Venture Capital Minority
Gaorong Ventures Venture Capital Minority
Lifespan Investments Venture Capital Minority
Cornell University University
To view Novita Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Novita Pharmaceuticals FAQs

  • When was Novita Pharmaceuticals founded?

    Novita Pharmaceuticals was founded in 2010.

  • Where is Novita Pharmaceuticals headquartered?

    Novita Pharmaceuticals is headquartered in New York, NY.

  • What is the size of Novita Pharmaceuticals?

    Novita Pharmaceuticals has 6 total employees.

  • What industry is Novita Pharmaceuticals in?

    Novita Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Novita Pharmaceuticals a private or public company?

    Novita Pharmaceuticals is a Private company.

  • What is Novita Pharmaceuticals’s current revenue?

    The current revenue for Novita Pharmaceuticals is .

  • How much funding has Novita Pharmaceuticals raised over time?

    Novita Pharmaceuticals has raised $49.6M.

  • Who are Novita Pharmaceuticals’s investors?

    Cloudstone Capital, Gaorong Ventures, Lifespan Investments, and Cornell University have invested in Novita Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process